While GLP-1 costs remain higher than bariatric surgery, retail prices will come down over time, especially in 2032 (when initial patents run out and generics appear), but probably not to the level of Dexatrim, phen-phen and similar blockbuster, yet faddish, weight-loss pills from yesteryear
observed no statistically significant differences in disease exacerbation, corticosteroid-free remission, or therapy escalation in the same cohort of 224 IBD patients after one year of GLP-1 RAs treatment
We manage these with site rotation, electrolyte balancing, and dose adjustments
To ensure that people do not take GLP-1 drugs without a medical prescription and to curb malpractices, the Drug Controller General of India, in collaboration with State Drug Controllers, took the following actions: On 10th March 2026, a comprehensive advisory was issued to all drug manufacturers to stop misleading advertisements and any promotion that could encourage people to use GLP-1 drugs without a prescription
The primary drivers
If you know more about this story contact [email protected]
